掃碼開(kāi)始閱讀
Scan to preview the contents.
Pharma Sources Insight April 2023 focuses on the following topics
SPONSORED BY
-ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD
FROM THE EDITOR
-Trends in Approval of Traditional Chinese Medicines
BRAND STORY
-Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic media supplier for industrial scale production
APIs
-Against Liver Cancer, Statins Help Novel Liver Cancer Drug Development
-How Africa, Asia Could Benefit from Ticagrelor’s WHO Listing
-Proposal to Have Empagliflozin API as Option for Children with Type 2 Diabetes
PHARMACEUTICAL R&D
-Research Progress in Signaling Pathway and Related Drugs of Target GDF15
-Global Diabetes Market Outlook
PHARMA IN CHINA
-Popular Products and Companies at PharmaSources.com
-The Increasing ADC+CDMO Industry Collaboration
INDUSTRY INSIGHT
-FDA's Approval was Postponed Again, Chinese Innovative Pharmaceutical Companies Extend Their Businesses to the Middle East and North Africa
-Powered by AI, OpenAI Technology Promises a New Technological Revolution of Drug R&D
-Pharma Co-packaging Regulations
About Pharma Sources Insight
Pharma Sources Insight is a unique source of updated coverages on current events and deep insights into hot areas of the pharma industry, from China to the world. It follows up new developments with the leading drug-manufacturers in China which further affect the world.
Now, join PharmaSources.com to get access to news of the Chinese pharmaceutical enterprises and to witness industrial changes through the exclusive perspectives of our expert writers into crucial aspects of the pharmaceutical field, all under PharmaSources.com and CPHI & PMEC China.
往期回顧
第九期：
https://flbook.com.cn/c/LQXB6v43Qi
點(diǎn)擊鏈接，免費閱讀第九期
第八期：
https://flbook.com.cn/c/8RGEA8j7j0
Pharma Sources Insight,
Your FREE source of news and insights into China pharmaceutical industry,
and more!
合作咨詢(xún)
肖女士
021-33392297
Kelly.Xiao@imsinoexpo.com
2006-2025 上海博華國際展覽有限公司版權所有（保留一切權利）
滬ICP備05034851號-57
